| ID | Name | CAS | Properties |
logPoct/wat |
| 58-215-9 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, nonyl ester
|
|
3 | 5.258 |
| 58-249-2 |
4H-Cyclopenteno[2,3-e]pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro, 7-methyl
|
|
3 | 1.744 |
| 58-457-1 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-propyl-phosphorothioamidate
|
|
3 | 2.705 |
| 58-480-5 |
5-«alpha»-Androstan-3-«beta»-ol-17-«beta»-carboxylate, MeTMS
|
|
3 | 6.038 |
| 58-508-4 |
3,17-Bis[(trimethylsilyl)oxy]-5«beta»-androstane, (3«beta»,17«beta»)-
|
18880-48-3 |
3 | 7.469 |
| 58-624-5 |
2,6-Pyridinedicarboxylic acid, di(2,4,4-trimethylpentyl) ester
|
|
3 | 5.540 |
| 58-638-0 |
2,5-Diethyl-5-methyl-4-acetyl-1,3,4-oxadiazoline
|
|
3 | 1.715 |
| 58-811-7 |
24-Nor-5.beta.-cholestane-3.alpha.,7.alpha.,25-triol, TMS
|
|
3 | 10.742 |
| 58-886-5 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro, 8-methyl
|
|
3 | 0.826 |
| 59-007-9 |
4H-Cyclopenteno[2,3-e]pyrido[1,2-a]pyrimidin-4-one, 9-methyl
|
|
3 | 1.492 |
| 59-082-6 |
5-Pregnen-3«beta»,17«alpha»,20«alpha»-triol, (VDMS)2
|
|
3 | 7.331 |
| 59-126-7 |
1,3,2-Diazaphosphol-4-ene, 2-(diethylamino)-1,3-dibutyl-4,5-dimethyl-
|
141968-98-1 |
3 | 5.024 |
| 59-134-8 |
5-Androstene-3-«beta»,15-«alpha»,16-«alpha»,17-«beta»-tetrol, TMS
|
|
3 | 9.049 |
| 59-367-0 |
Cholanic acid, 3«beta»,7«beta»,12«beta»-trihydroxy, Me-DMES
|
|
3 | 10.285 |
| 59-804-4 |
benzaldehyde oxime, 2-hydroxy, 3-nitro, 5-(1,1,3,3-tetramethylbutyl)
|
|
3 | 3.822 |
| 59-894-5 |
2,6-Pyridinedicarboxylic acid, 2-methylhex-3-yl 4-octyl ester
|
|
3 | 5.579 |
| 59-897-2 |
5,5-Diethyl-2-(1-methylethyl)-4-isobutanoyl-1,3,4-oxadiazoline
|
|
3 | 2.987 |
| 60-181-4 |
1H-1,2,4-Triazole, 1-[2-(2,4-dichlorophenyl)-3-(1,1,2,2-tetrafluoroethoxy)propyl]-
|
112281-77-3 |
3 | 4.243 |
| 60-377-7 |
4-Quinolinol,4-ethenyl-1-ethyldecahydro-2-methyl-(2«alpha»,4«alpha»,4a«beta»,8a«alpha»
|
38463-59-1 |
3 | 2.576 |
| 60-519-9 |
1H-Imidazole, 1-(2,2,3,3,3-pentafluoro-1-oxopropyl)-
|
71735-32-5 |
3 | 1.721 |
| 60-576-6 |
L-Tryptophan, N(O,S)-ethoxycarbonyl, (S)-(+)-3-methyl-2-butyl ester
|
|
3 | 3.891 |
| 60-608-0 |
2-Octalen-1-one, 3,4a,8,8-tetramethyl, 4-(2-(3-furyl)ethyl))
|
|
3 | 5.190 |
| 60-814-1 |
[(1R,8R)-7-(Hydroxymethyl)-2,3,5,8-tetrahydro-1H-pyrrolizin-1-yl] (E)-4-hydroxy-3-methyl-but-2-enoate
|
|
3 | 0.091 |
| 60-877-2 |
5-Ethyl-2,5-dimethyl-4-acetyl-1,3,4-oxadiazoline
|
|
3 | 1.325 |
| 60-925-8 |
2,6-Pyridinedicarboxylic acid, 5-methoxy-3-methylpent-2-yl propyl ester
|
|
3 | 2.866 |
| 60-927-6 |
Pyrrolidino[1,2-e]-4H-1,3,5-dithiazine, 4-methyl-2-(2-methylpropyl)
|
|
3 | 3.607 |
| 60-952-8 |
1-[3,4-methylenedioxy-benzyl]piperazine -M, (desmethylen-methyl-), 2AC
|
|
3 | 1.285 |
| 61-249-8 |
5H-Dibenz[c,e]azepine, 6,7-dihydro-6-(2-propenyl)-
|
146-36-1 |
3 | 3.855 |
| 61-408-1 |
Isonipecotic acid, N-(2,6-difluoro-3-methylbenzoyl)-, propyl ester
|
|
3 | 3.079 |
| 61-543-1 |
Ergostanol (24«alpha»-methyl-5«alpha»-cholestan-3«beta»-ol), TMS
|
|
3 | 9.574 |
| 61-685-4 |
3,9-Diazaoctacyclo[9.3.22,10.0.03,9.04,8.05,15.07,16]tetradecane
|
|
3 | 1.333 |
| 61-842-9 |
5-Ethyl-5-methyl-4-propionyl-1,3,4-oxadiazoline
|
|
3 | 1.325 |
| 61-932-9 |
«alpha»-D-Glucopyranose, 1,2,3,4,6-pentakis-O-(trimethylsilyl)-
|
3327-61-5 |
3 | 6.075 |
| 62-108-3 |
3-«alpha»,6-«alpha»,7-«beta»-Trihydroxy-5-«beta»-cholic acid, methyl ester, TMS
|
|
3 | 9.115 |
| 62-117-3 |
1,3-Disiloxane, 1,3-diethoxy, 1,3-bis-(2-propenyl), 1,3-bis-(chloromethyl)
|
|
3 | 3.888 |
| 62-379-3 |
N-tert-Butyl-N-trifluoroacetyl-N'-trifluoroacetyl-N'-cyclopropyl-6-methylsulfanyl-1,3,5-triazine-2,4-diamine
|
|
3 | 3.345 |
| 62-390-0 |
7H-Furo[3,2-g][1]benzopyran-7-one, 2,3-dihydro-2-(1-hydroxy-1-methylethyl)-, (S)-
|
13849-08-6 |
3 | 1.867 |
| 62-401-7 |
5-[2-(4-Allyl-2,6-dimethoxy-phenoxy)-1-hydroxy-propyl]-2-methoxy-phenol, TES
|
|
3 | 9.691 |
| 62-445-9 |
O-(2-Chloroethyl)-O-(1,1-difluoro-2-chloroethyl)-phosphorothiochloridate
|
|
3 | 3.553 |
| 62-451-2 |
6,7,8,9,10,11-Hexahydro-5,11a-diaza -cycloocta[b]naphthalen-12-one
|
|
3 | 2.513 |
| 62-526-9 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro, 2-methyl
|
|
3 | 0.888 |
| 62-903-0 |
1,5,6-Triazabicyclo[3.1.0]hexane, 4,4-dimethyl-2,2,6-tris(trifluoromethyl)-
|
95388-86-6 |
3 | 3.526 |
| 62-967-0 |
2,3-Dihydro-1H-pyrrolo[2,1-b]quinazolin-9-one
|
|
3 | 1.343 |
| 62-983-2 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, tridecyl ester
|
|
3 | 6.819 |
| 63-058-8 |
4-Quinolinol,1,4-diethyldecahydro-2-methyl-(2«alpha»,4«alpha»,4a«alpha»,8a«beta»
|
38463-60-4 |
3 | 2.800 |
| 63-239-7 |
4-Quinolinol, 4-ethynyldecahydro-1,2-dimethyl-, (2«alpha»,4«alpha»,4a«beta»,8a«alpha»)-
|
16067-45-1 |
3 | 1.634 |
| 63-419-7 |
1,3-Disiloxane, 1,3-dimethyl, 1,3-bis-(chloromethyl), 1,3-bis-(3-chloropropyl)
|
|
3 | 4.967 |
| 63-461-0 |
Benzofuran-2,3-dione, 2-[O-(2-acetoxyethyl)oxime], 3-(O-methyloxime), isomer 1
|
|
3 | 1.323 |
| 63-474-6 |
Hexahydro-3,3,5-trimethyl-2-p-tolyl-1,4,2-diazaphosphorine-2-oxide
|
|
3 | 2.216 |
| 63-513-2 |
5«alpha»-Androstane-2«beta»,3«beta»,17«beta»-triol, TMS
|
|
3 | 8.299 |
| 63-550-1 |
[7-(Hydroxymethyl)-2,3,5,8-tetrahydro-1H-pyrrolizin-1-yl] 1H-pyrrole-3-carboxylate
|
|
3 | 0.719 |
| 63-753-6 |
1,3-Propanediol, 2,2-dimethyl-, cyclic 2,2-dichloro-vinyl phosphonate
|
116402-11-0 |
3 | 3.461 |
| 64-017-2 |
10-Methyl-7,8,9,10-tetrahydro-6H-azepino[2,1-b]quinazolin-12-one
|
|
3 | 2.684 |
| 64-074-9 |
2-Pyridinecarbamic acid, 5,6-diamino-4-[(diphenylmethyl)amino]-, ethyl ester
|
38359-68-1 |
3 | 4.016 |
| 64-078-5 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, tridecyl ester
|
|
3 | 8.431 |
| 64-153-1 |
4,8-Secosenecionan-8,11,16-trione, 15,20-dihydro-12-(acetyloxy)-20-chloro-15-hydroxy-4-methyl-
|
60367-00-2 |
3 | 0.992 |
| 64-263-9 |
1«beta»,2«beta»-Epoxy-7-hydroxy-1«alpha»-methoxymethyl-8«alpha»-pyrrolizidine
|
|
3 | -0.781 |
| 64-652-7 |
N-tert-Butyl-6-methoxy-1,3,5-triazine-2,4-diamine
|
30125-64-5 |
3 | 0.673 |
| 64-675-2 |
(24S)-24-ethyl-5«alpha»-cholestan-3«beta»,24-diol, TMS
|
|
3 | 10.938 |
| 64-868-8 |
2-((E)-[((e)-2-([(e)-(2-hydroxyphenyl)methylidene]amino)-1-methylethyl)imino]methyl)phenol
|
|
3 | 3.024 |
| 64-888-6 |
5-(4-Chlorophenyl)-6-ethylpyrimidine-2,4-diamine, N,N'-bis(pentafluoropropionyl)-
|
|
3 | 5.632 |
| 64-989-4 |
1,3,5-triazine-2,4,6(1H,3H,5H)-trione trihydrazone
|
10105-42-7 |
3 | -2.272 |
| 64-991-1 |
5-«beta»-Androstan-3-«alpha»-ol-17-«beta»-carboxylate, MeTMS
|
|
3 | 6.038 |
| 65-071-1 |
6-isopropyl-4-methyl-7,8-dihydro-6H-naphtho[1,8-bc]furan (acorafuran)
|
|
3 | 4.427 |
| 65-189-1 |
11H-Pyrido[2,1-b]quinazolin-11-one, 6,7,8,9-tetrahydro, 9-methyl
|
|
3 | 2.294 |
| 65-194-5 |
2H-Pyrido[2,1-b]quinazolin-6-one, 1,3,4,6,7,8,9,10-octahydro-7-methyl
|
|
3 | 1.499 |
| 65-262-9 |
4,5,6,7-Tetrahydropyrazolo[1,5-d][1,2,4]-triazin-4-one, 2,5-dimethyl
|
|
3 | -0.629 |
| 65-352-9 |
1,2,3,4,5,6-hexahydro-(7H)-cyclopentapyridine-7-one
|
|
3 | 1.161 |
| 65-385-3 |
(Z)-10-Dodecenoic acid, 9,12-dioxo, methyl ester, bis-PFB-oxime, # 2
|
|
3 | 7.613 |
| 65-405-0 |
2,5-Diethyl-5-methyl-4-propionyl-1,3,4-oxadiazoline
|
|
3 | 2.105 |
| 66-067-5 |
1,2,3,4,5,7,8,9,10,11-Decahydro-5a,12-diaza-benzo[1,2;4,5]dicyclohepten-6-one
|
|
3 | 2.239 |
| 66-183-6 |
Isomer of 1«beta»,2«beta»-Epoxy-1«alpha»-hydroxymethyl-8«alpha»-pyrrolizidine
|
|
3 | -0.406 |
| 66-377-1 |
1,3,4-Thiadiazole-2(3H)-thione, 3,5-dimethyl-
|
|
3 | 1.520 |
| 66-378-0 |
2,4(1H,3H)-Pyrimidinedione, 5-[bis(2-chloroethyl)amino]-
|
|
3 | -0.617 |
| 66-566-1 |
«beta»-D-Xylopyranose, 1,2,3,4-tetrakis-O-(trimethylsilyl)-
|
18623-27-3 |
3 | 4.854 |
| 66-691-2 |
allo-Cholanic acid, 3«beta»,7«beta»,12«alpha»-trihydroxy, Me-TMS
|
|
3 | 9.115 |
| 66-692-1 |
Cholanic acid, 3«beta»,7«alpha»,12«beta»-trihydroxy, Me-TMS
|
|
3 | 9.115 |
| 66-693-0 |
allo-Cholanic acid, 3«alpha»,7«beta»,12«beta»-trihydroxy, Me-TMS
|
|
3 | 9.115 |
| 66-694-9 |
Cholanic acid, 3«alpha»,7«alpha»,12«alpha»-trihydroxy, Me-TMS
|
|
3 | 9.115 |
| 66-695-8 |
Cholanic acid, 3«alpha»,7«beta»,12«beta»-trihydroxy, Me-TMS
|
|
3 | 9.115 |
| 66-696-7 |
allo-Cholanic acid, 3«beta»,7«alpha»,12«alpha»-trihydroxy, Me-TMS
|
|
3 | 9.115 |
| 66-744-3 |
D-Fructose, 1,3,4,5,6-pentakis-O-(trimethylsilyl)-
|
19126-98-8 |
3 | 5.919 |
| 66-759-7 |
Methylthiophosphonic acid, O-isobutyl, S-2-(2-(diethylaminoethylthio)ethyl) ester
|
|
3 | 4.290 |
| 67-066-5 |
5«beta»-Androstane-3«alpha»,17«beta»-diol,bis-TMS
|
|
3 | 7.469 |
| 67-307-7 |
«beta»-D-Galactofuranose, 1,2,3,5,6-pentakis-O-(trimethylsilyl)-
|
7045-52-5 |
3 | 6.075 |
| 67-311-2 |
1,2,3,5,6,7,8,9-Octahydro-3a,10-diaza-cyclohepta[f]inden-4-one
|
|
3 | 1.458 |
| 67-520-0 |
(24S)-24-ethyl-5.alpha.-cholestan-3.beta.,24-diol, DMESI
|
|
3 | 11.718 |
| 67-584-0 |
Methylthiophosphonic acid, O-ethyl, S-(8-diisopropylamino)-1,3,6-trithiaoctyl ester
|
|
3 | 5.770 |
| 67-723-5 |
Silane, [[(3«alpha»,5«beta»,20S)-pregnane-3,20-diyl]bis(oxy)]bis[trimethyl-
|
16134-56-8 |
3 | 8.105 |
| 67-819-9 |
5«beta»-Pregnane-3«alpha»,20«alpha»-diol, (3-O)-TMSi, (20-O)-TBDMSi
|
|
3 | 9.276 |
| 68-191-5 |
O-(2-Bromo-1,1-difluoroethyl)-N-(1-methylpropyl)amidoethanethionophosphonate
|
|
3 | 3.708 |
| 68-259-0 |
5-(4-Chlorophenyl)-6-ethylpyrimidine-2,4-diamine, N,N'-bis(heptafluorobutyryl)-
|
|
3 | 6.902 |
| 68-337-3 |
1,3,5(10)-Oestratriene-2-methoxy-3,17«beta»-diol, 3-TMS-17-HFB
|
|
3 | 7.510 |
| 68-497-6 |
Phosphonothioic acid, methyl-, S-(2-(diethylamino)ethyl) O-ethyl ester
|
21770-86-5 |
3 | 2.921 |
| 68-700-9 |
3-Pyridineacetic acid, 1,4-dihydro-1-methyl-, methyl ester
|
|
3 | 1.283 |
| 68-737-9 |
2,3,4,6,7,8,9,10-Octahydro-1H-cyclohepta[d]pyrido[1,2-a]pyrimidin-11-one
|
|
3 | 1.848 |
| 68-764-9 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, isobutyl ester
|
|
3 | 4.776 |
| 68-784-7 |
3«alpha»,16«alpha»-dihydroxy-5«beta»-androstan-17-one, TMS
|
|
3 | 6.648 |
| 68-918-8 |
Benzenaminium, 2-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt
|
|
3 | 0.957 |
| 69-084-3 |
2-keto,3-methyl-5.alpha.-androstan-17.beta.-ol, monoTBDMS
|
|
3 | 7.235 |
|
« Previous Results
Next Results »
|